Correction: Directed evolution of human heavy chain variable domain (V H) using in vivo protein fitness filter (PLoS ONE (2014) 9, 6 (e98178) DOI: 10.1371/journal.pone.0098178);Directed evolution of human heavy chain Variable Domain (VH) using in vivo protein fitness filter

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Kim, Dong Sik ^a   Song, Hyung Nam ^b,c   Nam, Hyo Jung ^a   Kim, Sung Geun ^a   Park, Young Seoub ^a   Park, Jae Chan ^a   Woo, Eui Jeon ^b   Lim, Hyung Kwon ^a  

^a Mogam Biotechnology Research Institute   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; HYBRID PROTEIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; SCAFFOLD PROTEIN; TRANSACTIVATOR PROTEIN; TRYPTOPHAN; COMPLEMENTARITY DETERMINING REGION; IMMUNOGLOBULIN VARIABLE REGION;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ESCHERICHIA COLI; HUMORAL IMMUNITY; HYDROGEN BOND; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGE DISPLAY; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN STABILITY; QUALITY CONTROL; SOLVATION; THERMODYNAMICS; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOPHYSICS; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; COMPLEMENTARITY DETERMINING REGION; DIRECTED MOLECULAR EVOLUTION; GENETICS; GERM CELL; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; PHYSIOLOGICAL STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; PROTEIN DENATURATION; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE; REPRODUCIBILITY; SOLUBILITY;

AMINO ACID SEQUENCE; ANIMALS; BIOPHYSICAL PHENOMENA; CIRCULAR DICHROISM; COMPLEMENTARITY DETERMINING REGIONS; DIRECTED MOLECULAR EVOLUTION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GERM CELLS; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN DENATURATION; PROTEIN ENGINEERING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; REPRODUCIBILITY OF RESULTS; SOLUBILITY; STRESS, PHYSIOLOGICAL; THERMODYNAMICS;

EID: 84902491519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102631     Document Type: Erratum

References (40)

1. Els Conrath K, Lauwereys M, Wyns L, Muyldermans S (2001) Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs. J Biol Chem 276: 7346-7350.
2. Bargou R, Leo E, Zugmaier G, Klinger M, Goebeler M, et al. (2008) Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science 321: 974-977.
3. Tijink BM, Laeremans T, Budde M, Stigter-van Walsum M, Dreier T, et al. (2008) Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Mol. Cancer Ther 7: 2288-2297.
4. Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K, et al. (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol 198: 157-74.
5. Enever C, Batuwangala T, Plummer C, Sepp A (2009) Next generation immunotherapeutics-honing the magic bullet. Curr Opin Biotechnol 20: 405-411.
6. Hudson PJ, Souriau C (2003) Engineered antibodies. Nat Med 9: 129-134.
7. Ward ES, Güssow D, Griffiths AD, Jones PT, Winter G (1989) Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature, 341: 544-546.
8. Dolk E, van Vliet C, Perez JM, Vriend G, Darbon H, et al. (2005) Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. javascript:AL-get(this, 'jour', 'Proteins.')Proteins;59: 555-564.
9. Ewert S, Cambillau C, Conrath K, Plückthun A (2002) Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains. Biochemistry javascript:AL-get(this, 'jour', 'Biochemistry.');41: 3628-3636.
10. Kortt AA, Guthrie RE, Hinds MG, Power BE, Ivancic N, et al. (1995) Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41. J Protein Chem 14: 167-178.
11. Davies J, Riechmann L (1994) 'Camelising' human antibody fragments: NMR studies on VH domains. FEBS Lett 339: 285-290.
12. Aires da Silva F, Santa-Marta M, Freitas-Vieira A, Mascarenhas P, Barahona I, et al. (2004) Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity. J Mol Biol 340: 525-542.
13. Riechmann L (1996) Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain. J Mol Biol 259: 957-969.
14. Jespers L, Schon O, Famm K, Winter G (2004) Aggregation-resistant domain antibodies selected on phage by heat denaturation. Nat Biotechnol 22: 1161-1165.
15. Barthelemy PA, Raab H, Appleton BA, Bond CJ, Wu P, et al. (2008) Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains. J Biol Chem 283: 3639-3654.
16. To R, Hirama T, Arbabi-Ghahroudi M, MacKenzie R, Wang P, et al. (2005) Isolation of monomeric human V(H)s by a phage selection. J Biol Chem 280: 41395-41403.
17. Wigley WC, Stidham RD, Smith NM, Hunt JF, Thomas PJ (2001) Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein. Nat Biotechnol 19: 131-136.
18. Cabantous S, Terwilliger TC, Waldo GS (2005) Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 23: 102-107.
19. Karlsson AJ, Lim HK, Xu H, Rocco MA, Bratkowski MA, et al. (2012) Engineering antibody fitness and function using membrane-anchored display of correctly folded proteins. J Mol Biol 416: 94-107.
20. Fisher AC, DeLisa MP (2009) Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery. J Mol Biol 385: 299-311.
21. Ribnicky B, Van Blarcom T, Georgiou G (2007) A scFv antibody mutant isolated in a genetic screen for improved export via the twin arginine transporter pathway exhibits faster folding. J Mol Biol 369: 631-639.
22. Fisher AC, Kim W, DeLisa MP (2006) Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci 15: 449-458.
23. Silence K, Lauwereys M, De Haard H (2011) Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor. EP2390268A1.
24. Jespers L, Schon O, James LC, Veprintsev D, Winter G (2004) Crystal structure of HEL4, a soluble, refoldable human V(H) single domain with a germ-line scaffold. J Mol Biol 337: 893-903.
25. Rothe C, Urlinger S, Löhning C, Prassler J, Stark Y, et al. (2008) The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J Mol Biol 376: 1182-1200.
26. Lim HK, Mansell TJ, Linderman SW, Fisher AC, Dyson MR, et al. (2009) Mining mammalian genomes for folding competent proteins using Tat-dependent genetic selection in Escherichia coli. Protein Sci 18: 2537-2549.
27. Gohlke U, Pullan L, McDevitt CA, Porcelli I, de Leeuw E, et al. (2005) The TatA component of the twin-arginine protein transport system forms channel complexes of variable diameter. Proc Natl Acad Sci USA 102: 10482-10486.
28. Lee PA, Tullman-Ercek D, Georgiou G (2006) The bacterial twin-arginine translocation pathway. Annu Rev Microbiol 60: 373-395.
29. Oates J, Mathers J, Mangels D, Kühlbrandt W, Robinson C, et al. (2003) Consensus structural features of purified bacterial TatABC complexes. J Mol Biol 330: 277-286.
30. DeLisa MP, Tullman D, Georgiou G (2003) Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci USA 100: 6115-6120.
31. Berks BC, Palmer T, Sargent F (2005) Protein targeting by the bacterial twin-arginine translocation (Tat) pathway. Curr Opin Microbiol 8: 174-181.
32. Foit L, Morgan GJ, Kern MJ, Steimer LR, von Hacht AA, et al. (2009) Optimizing protein stability in vivo. Mol Cell 36: 861-871.
33. Joubert MK, Luo Q, Nashed-Samuel Y, Wypych J, Narhi LO (2011) Classification and characterization of therapeutic antibody aggregates. J Biol Chem 286: 25118-25133.
34. Christ D, Famm K, Winter G (2007) Repertoires of aggregation-resistant human antibody domains. Protein Eng Des Sel 20: 413-416.
35. Jung TY, Li D, Park JT, Yoon SM, Tran PL, et al. (2012) Association of novel domain in active site of archaic hyperthermophilic maltogenic amylase from Staphylothermus marinus. J Biol Chem 287: 7979-7989.
36. Bleicher L, Prates ET, Gomes TC, Silveira RL, Nascimento AS, et al. (2011) Molecular basis of the thermostability and thermophilicity of laminarinases: X-ray structure of the hyperthermostable laminarinase from Rhodothermus marinus and molecular dynamics simulations. J Phys Chem B 115: 7940-7949.
37. Dudgeon K, Rouet R, Kokmeijer I, Schofield P, Stolp J, et al. (2012) General Strategy for the generation of human antibody variable domains with increased aggregation resistance. Proc Natl Acad Sci USA 109: 10879-10884.
38. Shaw BF, Schneider GF, Bilgiçer B, Kaufman GK, Neveu JM, et al. (2008) Lysine acetylation can generate highly charged enzymes with increased resistance toward irreversible inactivation. Protein Sci 17: 1446-1455.
39. Schellekens H (2002). Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev Drug Discov 1: 457-462.
40. Hermeling S, Crommelin DJ, Schellekens H, Jiskoot W (2004). Structure immunogenicity relationships of therapeutic proteins. Pharm Res 21: 897-903.